PRELUDE CAPITAL MANAGEMENT, LLC - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$693,329
+108.3%
10,322
+114.1%
0.04%
+104.5%
Q2 2023$332,863
-56.9%
4,822
-69.9%
0.02%
-52.2%
Q1 2023$771,520
-28.4%
16,000
-25.9%
0.05%
-17.9%
Q4 2022$1,078,272
+46.9%
21,600
+20.0%
0.06%
+115.4%
Q3 2022$734,000
-25.9%
18,0000.0%0.03%
-7.1%
Q2 2022$990,000
+54.4%
18,000
+2.0%
0.03%
+55.6%
Q1 2022$641,00017,6500.02%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2022
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders